Bausch + Lomb Highlights Two Pipeline Assets in R&D Webinar
Event summary
- Bausch + Lomb to host second R&D 'Teach-in' webinar on June 1, 2026, at 1:00 p.m. ET.
- Executive VP of R&D Yehia Hashad, MD, to discuss two contact lens assets in development.
- First asset is a bioactive contact lens with polymerized hyaluronic acid for all-day comfort.
- Second asset is a silicone hydrogel daily contact lens designed to slow myopia progression.
- Citi hosting the event as part of its Head, Shoulders, Knees, and Toes series.
The big picture
Bausch + Lomb's focus on innovative contact lens technologies aligns with the growing demand for solutions addressing myopia and comfort in eye health. The company's emphasis on R&D highlights its strategic push to differentiate itself in a competitive market, particularly as the global contact lens market continues to grow. The inclusion of Citi in hosting the event underscores the significance of the pipeline updates to investors.
What we're watching
- Pipeline Execution
- Whether Bausch + Lomb can successfully develop and commercialize its two promising contact lens assets.
- Market Differentiation
- How the company's new contact lens materials will position it against competitors in the eye health sector.
- Myopia Market Growth
- The pace at which the myopia market expands and whether Bausch + Lomb's solution can capture significant market share.